Wei MJ - Search Results

1

Reversing multidrug resistance by tyrosine kinase inhibitors.

He M, Wei MJ. He M, et al. Among authors: wei mj. Chin J Cancer. 2012 Mar;31(3):126-33. doi: 10.5732/cjc.011.10315. Epub 2012 Jan 9. Chin J Cancer. 2012. PMID: 22237041 Free PMC article. Review.

2

Silencing of estrogen receptor alpha (ERalpha) gene by promoter hypermethylation is a frequent event in Chinese women with sporadic breast cancer.

Zhao L, Wang L, Jin F, Ma W, Ren J, Wen X, He M, Sun M, Tang H, Wei M. Zhao L, et al. Breast Cancer Res Treat. 2009 Sep;117(2):253-9. doi: 10.1007/s10549-008-0192-1. Epub 2008 Sep 24. Breast Cancer Res Treat. 2009. PMID: 18814026

3

Neuroprotective effects of (-)-epigallocatechin-3-gallate on aging mice induced by D-galactose.

He M, Zhao L, Wei MJ, Yao WF, Zhao HS, Chen FJ. He M, et al. Among authors: wei mj. Biol Pharm Bull. 2009 Jan;32(1):55-60. doi: 10.1248/bpb.32.55. Biol Pharm Bull. 2009. PMID: 19122281 Free article.

4

Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women.

Zhao L, Yu Z, Li Y, Wen X, Ma W, Wang L, Ren J, Liu C, He M, Bai X, Sun M, Zheng Z, Mi X, Wang E, Olopade OI, Jin F, Wei M. Zhao L, et al. Med Oncol. 2012 Sep;29(3):1569-75. doi: 10.1007/s12032-011-0107-6. Epub 2011 Nov 22. Med Oncol. 2012. PMID: 22105146

5

miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.

Li Z, Huang H, Chen P, He M, Li Y, Arnovitz S, Jiang X, He C, Hyjek E, Zhang J, Zhang Z, Elkahloun A, Cao D, Shen C, Wunderlich M, Wang Y, Neilly MB, Jin J, Wei M, Lu J, Valk PJM, Delwel R, Lowenberg B, Le Beau MM, Vardiman J, Mulloy JC, Zeleznik-Le NJ, Liu PP, Zhang J, Chen J. Li Z, et al. Nat Commun. 2012 Feb 21;3:688. doi: 10.1038/ncomms1681. Nat Commun. 2012. PMID: 22353710 Free PMC article.

6

Roles of ABCB1 gene polymorphisms and haplotype in susceptibility to breast carcinoma risk and clinical outcomes.

Wu H, Kang H, Liu Y, Tong W, Liu D, Yang X, Lian M, Yao W, Zhao H, Huang D, Sha X, Wang E, Wei M. Wu H, et al. J Cancer Res Clin Oncol. 2012 Sep;138(9):1449-62. doi: 10.1007/s00432-012-1209-z. Epub 2012 Apr 19. J Cancer Res Clin Oncol. 2012. PMID: 22526155

7

Two isoforms of HOXA9 function differently but work synergistically in human MLL-rearranged leukemia.

He M, Chen P, Arnovitz S, Li Y, Huang H, Neilly MB, Wei M, Rowley JD, Chen J, Li Z. He M, et al. Blood Cells Mol Dis. 2012 Aug 15;49(2):102-6. doi: 10.1016/j.bcmd.2012.05.003. Epub 2012 May 25. Blood Cells Mol Dis. 2012. PMID: 22633751 Free PMC article.

8

Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells.

Li Y, Zhao L, Sun H, Yu J, Li N, Liang J, Wang Y, He M, Bai X, Yu Z, Zheng Z, Mi X, Wang E, Wei M. Li Y, et al. PLoS One. 2012;7(8):e44254. doi: 10.1371/journal.pone.0044254. Epub 2012 Aug 28. PLoS One. 2012. PMID: 22952942 Free PMC article.

9

RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation.

He M, Sun HG, Hao JY, Li YL, Yu JK, Yan YY, Zhao L, Li N, Wang Y, Bai XF, Yu ZJ, Zheng ZH, Mi XY, Wang EH, Wei MJ. He M, et al. Among authors: wei mj. Oncol Rep. 2013 May;29(5):1721-9. doi: 10.3892/or.2013.2295. Epub 2013 Feb 21. Oncol Rep. 2013. PMID: 23440494 Free PMC article.

10

[Research on EGCG improving the degenerative changes of the brain in AD model mice induced with chemical drugs].

He M, Liu MY, Wang S, Tang QS, Yao WF, Zhao HS, Wei MJ. He M, et al. Among authors: wei mj. Zhong Yao Cai. 2012 Oct;35(10):1641-4. Zhong Yao Cai. 2012. PMID: 23627134 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters